Switch to:
More From Other Websites
Applied Genetic Up on Biogen Deal for Eye Disease Drugs - Analyst Blog Jul 03 2015
What You May Have Missed in Biotech: Celgene's $1B Bet on Cancer Immunotherapy, and a New CF Drug Jul 03 2015
Xoom Zooms, Teladoc Sinks a Day After Debut -- Tech Winners and Losers Jul 02 2015
Biogen: Where Did That Come From? Jul 02 2015
Applied Genetic Technologies (AGTC) Stock Climbs on $124 Million Biogen Deal Jul 02 2015
Biogen to Pay Applied Genetic $124 Million to Develop Eye-Disease Treatments Jul 02 2015
Biogen, AGTC Link Up To Develop Gene Therapy Jul 02 2015
Biogen deal pushes tiny company’s stock up by double digits Jul 02 2015
Biogen enters eye-treatment arena with AGTC deal Jul 02 2015
Biogen Opens Gene Therapy Partnership Worth About $1 Billion Jul 02 2015
Biogen And AGTC Enter Collaboration to Develop Gene Therapies in Ophthalmology Jul 02 2015
Biogen and AGTC Enter Collaboration to Develop Gene Therapies in Ophthalmology Jul 02 2015
AGTC to Host Conference Call and Webcast to Discuss Biogen Collaboration Jul 02 2015
AGTC to Host Conference Call and Webcast to Discuss Biogen Collaboration Jul 02 2015
Biogen and AGTC Enter Collaboration to Develop Gene Therapies in Ophthalmology Jul 02 2015
Biogen Invests in the Greater Zurich Area: Biopharmaceutical Plant in the Canton of Solothurn... Jul 01 2015
U.S. doctors, hospitals reap $6.5 bln from drug and device makers -report Jun 30 2015
Why is Celgene So Darn Expensive? Jun 30 2015
Why Alexion Stock Could Rip Jun 30 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK